• Open Account

Goldline Pharmaceutical Ltd

Small Cap | Pharmaceuticals
₹ 40.5 -0.74(-1.79%)
Last updated: 11-Aug-2026 , 16:01:17

Goldline Pharmaceutical Ltd Live Price Chart

Performance

Low: ₹40.5 High: 45.99
Previous Close ₹ 41.24
High ₹ 45.99
Volume 117000
52W Range ₹ 33 - ₹ 60
Open ₹ 42
Low ₹ 40.5
Market Cap ₹ 36.6 Cr

Goldline Pharmaceutical Ltd Technicals

Current Price
₹ 40.5 -0.74 (-1.79%)
EMASMA
20 Day ₹ 40.635
50 Day ₹ 42.874
100 Day ₹ 43.227
200 Day ₹ 43.227
20 Day ₹ 39.940
50 Day ₹ 42.339
100 Day ₹ 49.456
200 Day ₹ 73.488

Goldline Pharmaceutical Ltd Fundamentals

ROCE 28.352
P/E Ratio 0.000
P/B Ratio 1.620
Industry P/E 1.620
Debt to Equity 50.452
ROE 28.893
EPS 0.000
Dividend Yield 0.000
Book Value 25.055
Face Value 10.000

Goldline Pharmaceutical Ltd Financials

No data found

Goldline Pharmaceutical Ltd Shareholding Pattern

Promoter Holdings 57.292 %
FIIs 5.156 %
DIIs 7.813 %
MutualFund 0.000 %
Retail 25.136 %
Others - 4.604 %

About Goldline Pharmaceutical Ltd

Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai. Subsequently, Company was converted into a public limited Company and the name of Company was changed to Goldline Pharmaceutical Limited' w.e.f. September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand. Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Valiente. The pharmaceutical products marketed under the 'Goldline' brand are not manufactured by Company. Instead, they enter into contractual arrangements with third-party manufacturers, who produce the products based on market research, demand analysis, and specifications. Presently, Company maintain contractual arrangements with 15 manufacturers and 7 distributors, ensuring a stable supply chain and consistent market presence. Company extend comprehensive material supply and procurement support to hospitals and healthcare partners. Through the promoter group entities as Numerius Healthcare Pvt Ltd & Activista Healthcare Pvt Ltd, Company manage trading and supply chain operations, thereby ensuring reliable procurement, seamless distribution, and logistical efficiency. Company is planning the Initial Public Offer of 30,00,000 Equity Shares having the face value of Rs 10 e ...

FAQs on Goldline Pharmaceutical Ltd

1. Can I buy Goldline Pharmaceutical Ltd from PL Capital?

Yes, you can invest in Goldline Pharmaceutical Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Goldline Pharmaceutical Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Goldline Pharmaceutical Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Goldline Pharmaceutical Ltd pay dividends?

Goldline Pharmaceutical Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.

3. What is the current share price of Goldline Pharmaceutical Ltd ?

As of 11-Aug-2026 , 16:01:17 the share price for Goldline Pharmaceutical Ltd. is ₹ 40.5 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Goldline Pharmaceutical Ltd ?

The 52-week high and low of Goldline Pharmaceutical Ltd share price is ₹ 33 - ₹ 60 as of 11-Aug-2026 , 16:01:17 .
Open Your Demat Account
with PL Capital now
10 Lakh+ Active users
Award Winning research insights
No hidden charges
Start Stock SIP

Start SIP in Goldline Pharmaceutical Ltd

Invest systematically in stocks with the
PL Capital app

Get the App
Start SIP mobile app preview
App QR Code

Download the PL Capital App

Open Demat Account
×